CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Pluristem Therapeutics Incorporation. Company Snapshot
Pluristem Therapeutics Incorporation. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pluristem Therapeutics Incorporation. with three other pharmaceutical manufacturers in North America: Immunomedics, Inc. (2016 sales of $3.23 million of which 100% was Biopharma Products), Pediapharm Inc of Canada (3.75 million Canadian Dollars [US$2.79 million] ), and Procyon Corporation ($3.45 million ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Pluristem Therapeutics Incorporation.
  Stock Performance Chart for Pluristem Therapeutics Incorporation.
 
  Stock Data: Recent Stock Performance:
  Current Price (12/2/2016): 1.47
(Figures in U.S. Dollars)
1 Week -4.5%   13 Weeks -3.3%  
4 Weeks -10.9%   52 Weeks -5.2%  
 
Pluristem Therapeutics Incorporation. Key Data:
  Ticker: PSTI Country: Israel
  Exchanges: NAS OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 2,847,000
(Year Ending Jan 2017).
Employees: 177
  Currency: U.S. Dollars Market Cap: 118,746,895
  Fiscal Yr Ends: June Shares Outstanding: 80,780,201
  Share Type: Common Closely Held Shares: 5,751,091
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.